Skip to content

Clinical trials

Phase 3 Arthritis, Rheumatoid trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 3 Country / region: Australia Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
200512
20063
20074
20083
20097
20106
20115
20125
20135
20141
20154
20167
20172
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated9
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche14
Bristol-Myers Squibb8
Pfizer8
Eli Lilly and Company7
AbbVie6
Centocor, Inc.5
Gilead Sciences3
GlaxoSmithKline3
Sanofi3
UCB Pharma3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid71
Arthritis7
Joint Diseases7
Musculoskeletal Diseases6
Autoimmune Diseases1
Connective Tissue Diseases1
Fibrosis1
Lung Diseases, Interstitial1
Pulmonary Fibrosis1
Rheumatic Diseases1

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.